Tvm-Capital

📍 Berlin, DE
🏷️ vc
Visit Website ↗
Investment Thesis

TVM Capital Life Science invests in disruptive life science innovations with a two-pronged strategy: financing early-stage therapeutics through a strategic partnership with Eli Lilly and investing in differentiated commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics. The firm leverages AI-driven approaches in drug development and partners closely with portfolio companies to accelerate market adoption of transformative medical products.

Stage Focus
Early-stage therapeutics (via single asset company approach with Eli Lilly), commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Early-stage therapeutics, commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics with a focus on AI-driven drug development

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required

Investment Team (39)